Molecular and Clinical Characteristics of Patients with Non–Small Cell Lung Cancer Harboring KRAS Q61 Mutations to Assess Therapeutic Responses
Lea Ruge, Felix John, Malte Verheyen, Richard Riedel et autres
0 citationsClinical Cancer Research
Kato Kambartel
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
23Publications signalées
744Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesCancer Immunotherapy and BiomarkersCancer Diagnosis and Treatment
Publications récentes
Feasibility and safety of nintedanib in combination with nivolumab in pretreated patients with advanced or metastatic adenocarcinoma of the lung – An AIO phase Ib/II trial
Martin Reck, Cornelius Waller, Parvis Sadjadian, Kato Kambartel et autres
0 citationsLung Cancer
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)
Frank Griesinger, Wilfried Eberhardt, Wolfgang M. Brueckl, Horst-Dieter Hummel et autres
4 citationsJTO Clinical and Research Reports
Class II and class III BRAF mutations in patients with advanced non-small cell lung cancer (NSCLC): Clinical characteristics, mutation patterns, and survival outcomes.
Anna Rasokat, Anna Kron, Lucia Nogová, Udo Siebolts et autres
0 citationsJournal of Clinical Oncology
Therapiepause nach 2 Jahren Immuntherapie bei einer metabolischen Komplettremission beim NSCLC
Kato Kambartel, A. Yildirim, Patrick Stais, Peter Liebisch et autres
0 citationsPneumologie
Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis
Barbara Melosky, Kato Kambartel, Maik Häntschel, M Bennetts et autres
248 citationsMolecular Diagnosis & Therapy
Real-World Efficacy of Docetaxel Plus Nintedanib After Chemo-Immunotherapy Failure in Advanced Pulmonary Adenocarcinoma
Martin Metzenmacher, Filippo Rizzo, Kato Kambartel, Jens Panse et autres
8 citationsFuture Oncology
P37.17 Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutations in Non-small Cell Lung Cancer (NSCLC): A Global Meta-analysis
B. Melosky, Eckart Laack, Kato Kambartel, Maik Häntschel et autres
1 citationJournal of Thoracic Oncology
Genetic Heterogeneity of MET-Aberrant NSCLC and Its Impact on the Outcome of Immunotherapy
Anna Kron, Matthias Scheffler, Carina Heydt, Lea Ruge et autres
71 citationsJournal of Thoracic Oncology
Management von leichtgradigen Pneumonitiden unter Immuntherapie. Nutzen von BAL und CO-Diffusionsmessung
Kato Kambartel, Peter Liebisch, Christian Mattonet, Robert J. Stark et autres
0 citationsPneumologie
Changing in Paradigm: thoracoscopic anatomical lung resection with VO2max under 10 ml/kg/min is still possible
Alison Berzins, Uldis Kopeika, A.G. Arutyunyan, Kato Kambartel et autres
0 citationsZentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie
Lazarus-Type Tumour Response to Therapy with Nivolumab for Sarcomatoid Carcinomas of the Lung
Christian Roesel, Kato Kambartel, Uldis Kopeika, Alison Berzins et autres
23 citationsCurrent Oncology
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.